Filipa Lynce, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC (NCT06351332) | Filipa Lynce, MD | 2024-05-01 |
| TRUDI: TDXD+Durva in HER2+/Low IBC (NCT05795101) | Filipa Lynce, MD | 2023-05-04 |
Track Filipa Lynce, MD automatically
Every clearance here is in the API, with alerts when new ones post.